PDF(Sci-hub)
Abstract：
The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC.
摘要：
肝细胞癌（HCC）的管理指南于2003年首次制定，并于2009年由韩国肝癌研究小组和国家癌症中心修订。韩国。从那以后,在韩国和其他国家已经进行了许多关于HCC的研究。特别是,在诊断方面积累了大量的知识，分期,以及针对亚洲特征的治疗，尤其是韩国人,促使新战略的提出。因此，本文提出的新指南是根据最近的证据和专家意见制定的.该指南的主要目标是可疑或新诊断的HCC患者。该指南为新诊断的HCC患者的初始治疗提供了建议。
